SARS-CoV-2 and risk of psychiatric hospital admission and use of psychopharmaceuticals: A nationwide registry study of 4,585,083 adult Danish citizens

Abstract Background Current evidence on the risk of admission- or medication-requiring psychiatric sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is limited to selected populations, short durations, and loss to follow-up. This study examined if SARS-CoV-2 infect...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Valdemar Rømer, Pradeesh Sivapalan, Josefin Eklöf, Susanne D. Nielsen, Zitta B. Harboe, Tor Biering-Sørensen, Theis Itenov, Jens-Ulrik S. Jensen
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Cambridge University Press 2023-01-01
Σειρά:	European Psychiatry
Θέματα:	Long COVID psychiatry psychopharmaceuticals SARS-CoV-2
Διαθέσιμο Online:	https://www.cambridge.org/core/product/identifier/S0924933823024185/type/journal_article
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!